0001441844-11-000028.txt : 20110706 0001441844-11-000028.hdr.sgml : 20110706 20110706185559 ACCESSION NUMBER: 0001441844-11-000028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110701 FILED AS OF DATE: 20110706 DATE AS OF CHANGE: 20110706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ISRAEL ROBERT J CENTRAL INDEX KEY: 0001250274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 11954611 MAIL ADDRESS: STREET 1: 50 OXFORD DR CITY: MONTEBELLE STATE: NY ZIP: 10901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2011-07-01 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250274 ISRAEL ROBERT J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 Senior VP Medical Affairs Common Stock 2011-07-01 4 M 0 1000 5.33 A 37151 D Common Stock 2011-07-01 4 S 0 1000 7.205 D 36151 D Common Stock 2011-07-01 4 M 0 8322 5.46 A 44773 D Common Stock 2011-07-01 4 F 0 6930 7.4 D 37843 D ESPP (right to buy) 5.46 2011-07-01 4 M 0 8322 0 D 2011-07-01 2011-07-01 Common Stock 8322 0 D Non-Qualified Stock Option (right to buy) 5.33 2011-07-01 4 M 0 1000 0 D 2010-07-01 2019-07-01 Common Stock 1000 37000 D Non-Qualified Stock Option (right to buy) 7.4 2011-07-01 4 A 0 70000 0 A 2012-07-01 2021-07-01 Common Stock 70000 70000 D The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer. This transaction was executed in multiple trades at prices ranging from $7.02 to $7.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise. Includes shares of common stock acquired from the non-reportable exercise of a Grant under the Qualified Employee Stock Purchase Plan. Granted under the Company's Non-Qualified Employeee Stock Purchase Plan. The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The number of shares acquired upon exercise is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the exercise date. The stock options become exercisable in three equal annual installments, commencing one year from the grant date. By: Robert A. McKinney For: Robert J. Israel 2011-07-06